Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
about
Plasmacytoid dendritic cells regulate B-cell growth and differentiation via CD70Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms.Innate pathways to B-cell activation and tolerance.IL-21 acts as a promising therapeutic target in systemic lupus erythematosus by regulating plasma cell differentiation.Expression of BAFF and BR3 in patients with systemic lupus erythematosus.Pharmacokinetics and safety of single doses of tabalumab in subjects with rheumatoid arthritis or systemic lupus erythematosusMesenchymal stem cell transplantation reverses multiorgan dysfunction in systemic lupus erythematosus mice and humans.Balancing efficacy and toxicity of novel therapies in systemic lupus erythematosus.Serpins, immunity and autoimmunity: old molecules, new functions.Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.Generation of an artificial human B cell line test system using Transpo-mAbTM technology to evaluate the therapeutic efficacy of novel antigen-specific fusion proteins.Analysis of novel meningococcal vaccine formulations.T follicular helper cells, interleukin-21 and systemic lupus erythematosus.Association between nonspecific interstitial pneumonia and presence of CD20+ B lymphocytes within pulmonary lymphoid follicles.Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.Prolactin rescues and primes autoreactive B cells directly and indirectly through dendritic cells in B6.Sle3 mice.Circulating subsets and CD4(+)CD25(+) regulatory T cell function in chronic inflammatory demyelinating polyradiculoneuropathy.Cudrania tricupidata bureau (CTB) glycoprotein inhibits proliferation by Di(2-ethylhexyl) phthalate in primary splenocytes: responses in cell proliferation signaling.Interleukin-6 gene polymorphism in Iranian patients with systemic lupus erythematosus.B lymphocytes enhance interferon-α production by plasmacytoid dendritic cells
P2860
Q33805974-7326961D-E185-4BA5-A4E2-B9342EAE7233Q33965485-7F6D4DC1-4E1E-4170-AD50-9B0988B6813CQ36172913-C47640CE-99F3-4BFF-970B-6FC63985DEA1Q36302858-3015FFDB-5442-4E5F-90BE-D6CC7E430FB6Q36607723-703AE515-3EA1-4030-AC8F-06774CDE4916Q36806630-ADA23711-6FEB-4132-9796-F07004FCD871Q37246560-D0A50196-00E1-49B4-AE4E-39D9293F71EBQ37960525-3361D363-8868-433A-B7EF-C8C718204EDAQ38074594-2356CC14-E727-46F8-8A05-3B6C18F5EEA8Q38175493-3D915F58-852B-4CE9-9EAA-E3BDAA826F00Q38680881-A06AA871-5C19-42F0-95FF-CB4FAD7102A0Q38844408-2DF55195-A1BA-4F30-A88B-D8480F29F508Q38920904-F2ECB30D-D9E7-4040-90D4-36FF36D6DFFBQ47113769-999BFDAA-7DE0-4B83-B436-94723FBDB07FQ50705075-020417B6-8426-4A78-AE0C-72223CCCB993Q51076363-A99185DA-5F07-4662-9789-47A9656617AEQ51889320-C5A6610D-F578-438D-A543-5E9FA4486CCEQ53268774-CD7A9C1D-5DC5-4FAC-B22A-39D4C3E67BDDQ54432949-0CFF1DF3-B6C2-4326-ABDB-770F55138EA8Q58023370-D0D88F8E-9286-403C-B477-9AD6562961D2
P2860
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
@en
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
@nl
type
label
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
@en
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
@nl
prefLabel
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
@en
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
@nl
P2093
P2860
P356
P1433
P1476
Peripheral B cell abnormalities and disease activity in systemic lupus erythematosus.
@en
P2093
P2860
P304
P356
10.1177/0961203308095138
P577
2008-12-01T00:00:00Z